MIAMI, July 25, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences Inc. (Pink Sheets:GLSN) today announced that it has begun trading under its new name and symbol. Galea was formerly known as Value Holdings Inc.
The Company changed its name to better reflect its new direction in anticipation of the completion of its acquisition of Innovative Technology Acquisition Corp., and that company's Nutraplete dietary supplement. Nutraplete is designed to provide nutritional support for people with HIV/AIDS.
Concurrent with the name change the Company also executed a 25-1 reverse stock split.
About Innovative Technology Acquisition Corp.
Innovative Technology Acquisition Corp. is the developer of functional foods and dietary supplements. Innovative acquired BioSource Therapeutics, Inc. an entrepreneurial life science company, in 2002. BST specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies. www.nutraplete.com
About Galea Life Sciences
Galea Life Sciences, Inc. (Pink Sheets:GLSN) is currently a non reporting, over the counter ("OTC") publicly traded company. The Company's corporate goal is to build well-run independent subsidiaries that have solid market niches with compounded growth rates in terms of revenues and earnings.
Certain statements in this release constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "project," "intend," "expect" "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (finance or operating) or achievements to differ from future results, performance (financing and operating) or achievements expressed or implied by such forward-looking statements.
Statements herein express management's beliefs and expectations regarding future performance and are forward-looking and involve risks and uncertainties, including, but not limited to, the ability to negotiate outstanding prior debts of acquired companies; properly identify acquisition partners; adequately perform due diligence; manage and integrate acquired businesses; react to quarterly fluctuations in results; raise working capital and secure other financing; respond to competition and rapidly changing technology; deal with market and stock price fluctuations; and other risks.